Cremonini F
Division of Gastroenterology, Southern Nevada VA Healthcare System, Las Vegas, NV, USA; Las Vegas Gastroenterology and First Class Medicine, Las Vegas, NV, USA.
Neurogastroenterol Motil. 2014 Jul;26(7):893-900. doi: 10.1111/nmo.12384.
Symptom relief in functional gastrointestinal disorders (FGID) is frequently sought with complementary and alternative medicine, and various herbal medicine compounds are popular in different parts of the world. Only a few products, however, are standardized and are backed by scientific evidence. This review mainly focuses on mechanistic and clinical data in support of the Japanese traditional compound Rikkunshi-to (RKT) and of STW-5. Their effects on gut sensori-motor function, neurohormonal network, and controlled clinical data in FGID are revised. RKT and STW-5 appear to possess some degree of gastroprokinetic, visceral analgesic properties, and seem to increase the gastric accommodation response. Controlled trials of RKT and STW-5 support at least a modest effect on symptoms of functional dyspepsia and irritable bowel syndrome, with low side effects profile. With the widespread use of herbals and the relative paucity of effective pharmacological options for FGID, rigorous studies to further elucidate pharmacological actions and clinical applications of herbal compounds are a priority.
功能性胃肠疾病(FGID)患者常常寻求补充和替代医学来缓解症状,各种草药化合物在世界不同地区都很受欢迎。然而,只有少数产品是标准化的且有科学证据支持。本综述主要关注支持日本传统复方理气剂(RKT)和STW - 5的作用机制和临床数据。对它们在FGID中对肠道感觉运动功能、神经激素网络的影响以及对照临床数据进行了修订。RKT和STW - 5似乎具有一定程度的促胃动力、内脏镇痛特性,并且似乎能增强胃容纳反应。RKT和STW - 5的对照试验支持其对功能性消化不良和肠易激综合征症状至少有一定程度的疗效,且副作用较小。鉴于草药的广泛使用以及FGID有效药物选择相对较少,进一步阐明草药化合物药理作用和临床应用的严格研究是当务之急。